Organization: The World Hypertension League (WHL) is a non-profit, non-governmental organization comprised predominantly of volunteers dedicated to the prevention and control of hypertension globally to include awareness of non-communicable diseases. The WHL membership is currently comprised of 60 national hypertension societies who comprise our council. The WHL is incorporated in the United States and registered as a charitable organization in Canada with two contracted staff in Montana, USA who work in alliance with and coordinate efforts of the WHL Executive, Board, Council, Committees, partners, and volunteers. In 2014, Regional WHL China (Beijing) Office was launched and, in 2015, Regional WHL India (Hyderabab), Regional WHL Sub-Saharan Africa (Cameroon), and Regional WHL South America (Cordoba, Argentina) Offices were launched with Directors appointed at each office. More detailed descriptions of the WHL leadership, organizational structure, Mission, By-Laws, members, resources, newsletters, publications, and much more may be viewed and downloaded from our website. The WHL is in official relations with the International Society of Hypertension (ISH) and the World Health Organization (WHO). The Journal of Clinical Hypertension (JCH) is the official WHL journal.
Mission & Mandate: Hypertension is a driving force in the global epidemic of noncommunicable diseases (NCDs) and is the leading risk factor for death and disability globally. In 2010, it was estimated that increased blood pressure accounted for 17.8% of premature death (9.4 million deaths, 162 million years of life lost) and 7% of disability (173 million DALYs) globally. The burden of hypertension is greatest where resources are the lowest, with developing countries disproportionately impacted by hypertension. Over 14 million deaths from NCDs occur between the ages of 30 and 70 annually, of which 85% are in developing countries. Globally, it is estimated that approximately one half of people with hypertension are not aware they have it and that fewer than 20% are controlled. The World Economic Forum describes NCDs as the greatest threat to economic development, predicting a cumulative loss in global economic output of $47 trillion USD, or 5% of gross domestic product, by 2030. The importance of the WHL mission is emphasized by the recent United Nations (UN) Global Health Summit on NCDs which agreed to nine health targets to be achieved by 2025. The UN health targets included a 25% reduction in uncontrolled hypertension and a 30% reduction in dietary salt.
To help reduce this burden, the WHL is currently focused on the: 1) development of international and national partnerships, 2) use of strategic approaches to hypertension prevention and control, 3) enhancement of healthy environments through healthy public policy and especially through reduction in dietary salt, 3) information exchanges and knowledge translation, 4) utilization of evidence-based resources (e.g. Global Burden of Disease Study) to promote health and hypertension control, 5) promotion of high quality monitoring of population blood pressure levels, hypertension prevalence, diagnosis, treatment and control, and 6) providing resources that may be adopted particularly in vulnerable populations.
Vision & Core Values: The WHL is committed to optimizing and advancing prevention and control of hypertension through collaborative work with member organizations, like-minded governmental and non-governmental partner organizations, and Best Practices. We are committed to helping member organizations and their populations achieve 25-80% hypertension control. Through its various programs, the WHL seeks to assist a wide variety of organizations, individuals, health care providers, and communities throughout the world. The quality of the services provided is defined by adherence to our mission in terms of the following core values: Forward Thinking, Philanthropy, Passion, Transparency (Integrity), Knowledge Translation and Sharing, and Open Communication.